Recent Updates
Recently added Catalysts
BWAY Positive Sentiment

Deep transcranial magnetic stimulation alters resting-state neurophysiological traits in major depressive disorder

Key Takeaway: The study investigates the effects of Deep TMS on patients with major depressive disorder (MDD). It found that after 36 treatment sessions, there was a notable decrease in slow-frequency brain activity in the prefrontal cortex. Additionally, baseline QEEG measures accurately predicted treatment responses, suggesting that Deep TMS could be a valuable tool in treating MDD.
Price reaction · baseline $2.49 (2023-11-21 close) · hit pre-market · 11 other BWAY headline(s) in the window, move may be shared
day 0 close
+10.6%
day 1
+17.1%
day 3 · peak
+23.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Deep TMS shows effectiveness for treatment-resistant MDD.
  • Significant reduction in slow-frequency brain activity observed.
  • High accuracy in predicting treatment response with QEEG.

Full Press Release Details

Objective:

Major depressive disorder (MDD) stands as one of the most prevalent and incapacitating health conditions globally, and regrettably, numerous patients do not exhibit positive responses to first-generation antidepressant medication or talk therapy approaches. Deep transcranial magnetic stimulation (Deep TMS) has emerged as an effective intervention for cases deemed “treatment-resistant”; however, the precise mechanisms through which Deep TMS alleviates depressive symptoms remain unclear.

Methods:

In this current study, resting-state quantitative electroencephalography (QEEG) measures were examined before and after treatment to elucidate the neurophysiological changes induced by Deep TMS.

Results:

The findings revealed a decrease in slow-frequency brain activity (delta and theta waves) in the prefrontal cortex following 36 treatment sessions. Moreover, baseline QEEG measures demonstrated a 93% accuracy in predicting treatment response.

Conclusions:

These results offer initial evidence suggesting that TMS ameliorates depressive symptoms by reducing slow-wave brain activity in the prefrontal cortex.
The combination of Deep TMS with QEEG should persist as a valuable approach for MDD treatment in clinical practice. Furthermore, future investigations should explore the potential of this approach for addressing other neuropsychiatric conditions.
Full Article:

Frequently Asked Questions

What is the objective of the study on Deep TMS?

The study aims to investigate the neurophysiological changes induced by Deep TMS in patients with major depressive disorder.

What were the main findings of the Deep TMS study?

The study found a decrease in slow-frequency brain activity in the prefrontal cortex after treatment.

How accurate was the QEEG in predicting treatment response?

Baseline QEEG measures demonstrated a 93% accuracy in predicting treatment response.

What is the significance of Deep TMS for MDD treatment?

Deep TMS shows potential as an effective intervention for treatment-resistant major depressive disorder.

Last updated: Nov 22, 2023